Orgasm Inc: Female Sexual Dysfunction Is curable

Next month, an FDA advisory committee will meet to review a Boehringer Ingelheim pill to tackle FSD, or female sexual dysfunction . However, a growing group of psychologists, academics and public health advocates contend that FSD isn’t an authentic medical condition, or at least not the sort of problem that should be treated with drugs. Bandied about but never proven is the statistic that 43 percent of women suffer from this affliction (background).

And so just in time for the regulatory show comes a new documentary called Orgasm Inc. (subtitled The Strange Science of Female Pleasure), which premieres in New York on Thursday and explores the issue by examining a host of views and products, including the Orgasmatron and an effort by Vivus Pharmaceutical to develop and sell a topical treatment. “A lot of this is about marketing,” filmmaker Liz Canner tells Newsweek. “They are trying to sell disorders.” You can read more here.